Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Protara gears up for next commercial steps—Chutes & Ladders
Protara gears up for next steps with commercial pro. Instil installs Big Pharma vet as CMO. Orca hauls in Carvykti commercial leader.
Darren Incorvaia
,
Zoey Becker
Jun 6, 2025 8:30am
Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in
Jun 4, 2025 1:00pm
Gene editor shelves sole clinical asset, lays off 25% of staff
May 19, 2025 2:28pm
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am
FDA pushes back Cytokinetics' heart drug PDUFA to year-end
May 2, 2025 7:48am
M&A remains ‘top priority’ for pharmas in face of tariff threat
Apr 25, 2025 10:41am